Trial intelligence / Profile preview

Epidural chloroprocaine versus ropivacaine for unplanned Caesarean section

2016-000298-20Phase 3Terminated

Sponsor
Sintetica
Start
Sep 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of chloroprocaine and ropivacaine (2 arms), sponsored by Sintetica. Primary endpoint: Time to onset of anaesthesia. Started Sep 2016; status: terminated.

02

Drugs

chloroprocaineropivacaine

Beyond the preview

Go deeper on 2016-000298-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000298-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call